Patent ID: 8409584

Claim:
A pharmaceutical agent selected from the group consisting of a polymer of a first peptide comprising an amino acid sequence X 1a X 2a X 3a X 4a X 5a X 6a X 7a X 8a X 9a X 10a X 11a X 12a X 13a (SEQ ID NO: 19), wherein X 1a is C, M, S, or G; X 2a is T, S, or C; X 3a is K, R, or H; X 4a is S, T, or C; X 5a is V, I, or L; X 6a is R, K, or H; X 7a is R, K, or H; X 8a is Q or N; X 9a is L, I, or V; X 10a is L, I, or V; X 11a is D or E; X 12a is D or E; X 13a is Q or N; a polymer of a second peptide comprising an amino acid sequence X 1b X 2b X 3b X 4b X 5b X 6b X 7b X 8b X 9b X 10b X 11b X 12b X 13b (SEQ ID NO:20), wherein X 1b is C, M, S, or G; X 2b is F, Y, or W; X 3b is Q or N; X 4b is I, L, or V; X 5b is F, Y, or W; X 6b is I, L, or V; X 7b is Q or N; X 8b is T, S, or C; X 9b is N or Q; X 10b is D or E; X 11b is R, K, or H; X 12b is H, R, or K; X 13b is Y, W, or F; and a polymer of a fusion peptide comprising the first and/or second peptides.